|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.386 EUR | +3.71% |
|
+0.48% | -45.74% |
| Apr. 23 | European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading | MT |
| Apr. 23 | Grifols to Launch EUR1 Billion Note Offering | MT |
MADRID, March 21 (Reuters) - Beleaguered Spanish drugmaker Grifols will not be required to restate its accounts for the years 2021 and 2022, market regulator CNMV said on Thursday, as its investigation found no significant errors in the amounts it had reported.
(Reporting by David Latona and Jesus Aguado; Editing by Andrei Khalip)
| 1st Jan change | Capi. | |
|---|---|---|
| -45.74% | 5.41B | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| -9.14% | 11.95B | |
| +5.24% | 8.71B | |
| -8.42% | 8.12B |
GRIFOLS, S.A. 
